Is it time we changed the way we manage melanoma in situ of the trunk and limbs?

Smith, H; Hussain, W

Is it time we changed the way we manage melanoma in situ of the trunk and limbs?

Smith, H Hussain, W

Permalink

Publisher:: OXFORD UNIV PRESS
Publication Type:: Journal Article
Citation:: Br J Dermatol, 2023, 188, (5), pp. 685-687
Issue Date:: 2023-04-20

Closed Access

	Filename	Description	Size
	Is it time we changed the way we manage melanoma.pdf	Published version	617.47 kB	Adobe PDF	View/Open

Copyright Clearance Process

Recently Added
In Progress
Closed Access

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Smith, H
dc.contributor.author	Hussain, W https://orcid.org/0000-0003-0610-4006
dc.date.accessioned	2024-04-12T03:19:24Z
dc.date.available	2024-04-12T03:19:24Z
dc.date.issued	2023-04-20
dc.identifier.citation	Br J Dermatol, 2023, 188, (5), pp. 685-687
dc.identifier.issn	0007-0963
dc.identifier.issn	1365-2133
dc.identifier.uri	http://hdl.handle.net/10453/177811
dc.description.abstract	<jats:p>There is little evidence on the optimal clinical and histological margins required to reduce local recurrence in melanoma in situ (MIS). Our aim was to identify the number of lesions on the trunk and limbs with histological clearance &gt; 1 mm after initial narrow-margin excision. In our cohort 93.6% were considered clear after initial exclusion with no residual MIS seen when further wide local excision was carried out.</jats:p>
dc.format	Print
dc.language	eng
dc.publisher	OXFORD UNIV PRESS
dc.relation.ispartof	Br J Dermatol
dc.relation.isbasedon	10.1093/bjd/ljad031
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject	1103 Clinical Sciences, 1112 Oncology and Carcinogenesis
dc.subject.classification	Dermatology & Venereal Diseases
dc.subject.classification	3202 Clinical sciences
dc.subject.mesh	Humans
dc.subject.mesh	Melanoma
dc.subject.mesh	Skin Neoplasms
dc.subject.mesh	Extremities
dc.subject.mesh	Melanoma, Cutaneous Malignant
dc.subject.mesh	Extremities
dc.subject.mesh	Humans
dc.subject.mesh	Melanoma
dc.subject.mesh	Skin Neoplasms
dc.subject.mesh	Melanoma, Cutaneous Malignant
dc.subject.mesh	Humans
dc.subject.mesh	Melanoma
dc.subject.mesh	Skin Neoplasms
dc.subject.mesh	Extremities
dc.subject.mesh	Melanoma, Cutaneous Malignant
dc.title	Is it time we changed the way we manage melanoma in situ of the trunk and limbs?
dc.type	Journal Article
utslib.citation.volume	188
utslib.location.activity	England
utslib.for	1103 Clinical Sciences
utslib.for	1112 Oncology and Carcinogenesis
pubs.organisational-group	University of Technology Sydney
pubs.organisational-group	University of Technology Sydney/Faculty of Engineering and Information Technology
pubs.organisational-group	University of Technology Sydney/Faculty of Engineering and Information Technology/School of Computer Science
utslib.copyright.status	closed_access	*
dc.date.updated	2024-04-12T03:19:22Z
pubs.issue	5
pubs.publication-status	Published
pubs.volume	188
utslib.citation.issue	5

Abstract:

There is little evidence on the optimal clinical and histological margins required to reduce local recurrence in melanoma in situ (MIS). Our aim was to identify the number of lesions on the trunk and limbs with histological clearance > 1 mm after initial narrow-margin excision. In our cohort 93.6% were considered clear after initial exclusion with no residual MIS seen when further wide local excision was carried out.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/177811